TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04332029

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT + WGP + CM
Description: The intervention will be implemented in 8-week group-based sessions and includes: 1) A Cognitive Behavioral Treatment (CBT) for smoking cessation with quit date occurring at sixth session. Patients will be asked to reduce their nicotine intake gradually (i.e., 20% each week); 2) A Weight Gain Prevention module (WGP) which will consist on providing CBT and Dialectical-Behavioral Therapy (DBT) techniques targeting weight stability and associated disordered eating, and 3) a Contingency Management procedure reinforcing smoking abstinence. This component will consist on providing vouchers to reinforce abstinence contingent on biochemical verification. The schedule will incorporate an increasing magnitude of reinforcement.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT + WGP
Description: The intervention will be implemented in 8-week group-based sessions and will include only the first two components of the experimental intervention: 1) A Cognitive Behavioral Treatment (CBT) for smoking cessation with quit date occurring at sixth session. Patients will be asked to reduce their nicotine intake gradually (i.e., 20% each week); 2) A Weight Gain Prevention module (WGP) which will consist on providing CBT and Dialectical-Behavioral Therapy (DBT) techniques targeting weight stability and associated disordered eating.
Study: NCT02223221

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IVF/ICSI
Description: In vitro fertilization or intracytoplasmic sperm injection.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IVF/ICSI
Description: In vitro fertilization or intracytoplasmic sperm injection.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: PGS
Description: Selection of embryos are based on SNP-array-based preimplantation genetic screening for the number of all chromosomes on the 5th day of IVF/ICSI.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Without PGS
Description: Selection of embryos are based on morphology criteria on the 5th day of IVF/ICSI.
Study: NCT01506778

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tenaculum
Description: Single tooth tenaculum are use to the cervix for steady the cervix, straighten the cervicouterine angle and provide countertraction. Most of gynecological office procedure such as endometrial sampling procedure, hysterosalpingography, hysteroscopy, insertion of contraceptive intrauterine device, difficult intrauterine insemination or embryo transfer procedures often require the application of a tenaculum.
Study: NCT03828006

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Red Rice Yeast
Description: Participants will take one tablet per day of a dietary supplement based on red rice yeas for a period of six months

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group
Description: Participants of this group will take one tablet of placebo per day for a period of six months
Study: NCT03967158

Intervention type: DEVICE
Intervention: Xience Sierra stent
Description: Percutaneous coronary intervention with Xience Sierra stent
Study: NCT01250327

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Melody
Description: insertion of a pulmonic valved stent
Study: NCT03468192

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-precaution group
Description: Patients in the NPG had no restrictions on mobility, i.e. they were encouraged to move freely during the recovery phase and assistive equipment were prescribed only if needed
Study: NCT03195673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terazosin
Description: TZ 0.5mg once a day for 3-7 days before carotid artery stenting to 30 days later.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Description: Carotid artery stenting is an alternative treatment of carotid artery stenosis, which would be performed by experienced neuroradiologist according to the latest guideline from American Heart Association and American Stroke Association.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Carotid artery stenting
Description: Carotid artery stenting is an alternative treatment of carotid artery stenosis, which would be performed by experienced neuroradiologist according to the latest guideline from American Heart Association and American Stroke Association.
Study: NCT03066934

Intervention type: OTHER
Intervention: noninvasive ventilation respiratory support

Intervention type: OTHER
Intervention: noninvasive ventilation respiratory support
Study: NCT05440695

Intervention type: DEVICE
Intervention: Continuous non-invasive arterial pressure (Infinity® CNAPTM, Dräger)
Description: The basic working principle of CNAP is to keep the blood volume of the finger arteries constant by applying an exterior pressure to the vessel wall, that is done by an electronic system controlling the pressure inside a cuff around the finger. The pressure in the cuff, which is needed to keep the volume constant during arterial pulsation, corresponds to the AP.
Study: NCT03015857

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: phenylephrine
Description: - phenylephrine; a vasopressor drug given to prevent post spinal hypotension

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: - norepinephrine; a vasopressor drug given to prevent post spinal hypotension

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: intrathecal bupivacaine 10 mg will be given in both groups

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: intrathecal bupivacaine 10 mg will be given in both groups

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: intrathecal fentanyl 20 mcg will be given in both groups

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: intrathecal fentanyl 20 mcg will be given in both groups

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo (normal saline)
Study: NCT03558087

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 360mg will be administered on Day 1 of each 21 day cycle for four 21-day cycles. Based on response and a balanced patient-physician discussion, subjects may receive nivolumab 240 mg for 8 cycles (cycle = 14 days).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine 1000mg/m\^2 will be administered on Days 1 and 8 for four 21-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 70mg\^m2 will be administered on Day 1 for four 21-day cycles.
Study: NCT02617043

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: hypofractionated whole breast irradiation with simultaneously integrated boost
Description: deliver 40Gy/15Fx to whole breast with 48Gy/15fx simultaneously integrated to tumor bed
Study: NCT03221270

Intervention type: DEVICE
Group type: OTHER
Intervention: tACS treatment week
Description: 10 Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 20 minutes twice for 5 consecutive days.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tACS treatment week
Description: 10 Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 20 minutes twice for 5 consecutive days.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tACS sham week
Description: 10Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 10 seconds twice a day for 5 consecutive days.

Intervention type: DEVICE
Group type: OTHER
Intervention: tACS sham week
Description: 10Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 10 seconds twice a day for 5 consecutive days.

Intervention type: DEVICE
Group type: OTHER
Intervention: Maintenance tACS
Description: 10 Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 40 minutes once a weekly for 8 weeks.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Maintenance tACS
Description: 10 Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 40 minutes once a weekly for 8 weeks.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Maintenance Sham tACS
Description: 10Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 10 seconds once a week for 8 weeks.

Intervention type: DEVICE
Group type: OTHER
Intervention: Maintenance Sham tACS
Description: 10Hz sine wave stimulation with a peak-to-peak amplitude of 2 mA for 10 seconds once a week for 8 weeks.
Study: NCT02256657

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality Improvement Toolkit
Description: The quality improvement toolkit is comprised of standardized admission and discharge checklists, clinical pathways, an audit and feedback mechanism through electronic data capture, and a monthly report used in conjunction with root cause analysis meetings. Quality improvement toolkits are implemented by individual hospitals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality Improvement Toolkit
Description: The quality improvement toolkit is comprised of standardized admission and discharge checklists, clinical pathways, an audit and feedback mechanism through electronic data capture, and a monthly report used in conjunction with root cause analysis meetings. Quality improvement toolkits are implemented by individual hospitals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality Improvement Toolkit
Description: The quality improvement toolkit is comprised of standardized admission and discharge checklists, clinical pathways, an audit and feedback mechanism through electronic data capture, and a monthly report used in conjunction with root cause analysis meetings. Quality improvement toolkits are implemented by individual hospitals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality Improvement Toolkit
Description: The quality improvement toolkit is comprised of standardized admission and discharge checklists, clinical pathways, an audit and feedback mechanism through electronic data capture, and a monthly report used in conjunction with root cause analysis meetings. Quality improvement toolkits are implemented by individual hospitals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality Improvement Toolkit
Description: The quality improvement toolkit is comprised of standardized admission and discharge checklists, clinical pathways, an audit and feedback mechanism through electronic data capture, and a monthly report used in conjunction with root cause analysis meetings. Quality improvement toolkits are implemented by individual hospitals.
Study: NCT01984983

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate
Study: NCT02180087

Intervention type: DRUG
Group type: OTHER
Intervention: Ketoprofen
Study: NCT01984983

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% saline placebo
Study: NCT02180087

Intervention type: DRUG
Group type: OTHER
Intervention: Ketoprofen

Intervention type: DRUG
Group type: OTHER
Intervention: Ketoprofen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ketoprofen
Study: NCT04653714

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Description: Patients with periodontitis in the test group will be treated by conventional non-surgical root debridement and in the control group by low-intensive supragingival plaque removal with mechanical brush and professional tooth paste only.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Scaling and root planing
Description: Patients with periodontitis in the test group will be treated by conventional non-surgical root debridement and in the control group by low-intensive supragingival plaque removal with mechanical brush and professional tooth paste only.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic lozenges
Description: Patients with gingivitis in the test group will be treated with supragingival debridement and with probiotic lozenges with strains of Lactobacillus brevis and Lactobacillus plantarum once a day for 3 months and in the control group by low-intensive supragingival plaque removal, as a placebo treatment, and placebo probiotics lozenges.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Probiotic lozenges
Description: Patients with gingivitis in the test group will be treated with supragingival debridement and with probiotic lozenges with strains of Lactobacillus brevis and Lactobacillus plantarum once a day for 3 months and in the control group by low-intensive supragingival plaque removal, as a placebo treatment, and placebo probiotics lozenges.
Study: NCT02966158

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AIT Group
Description: The AIT Group will begin with a one-month, run-in period where patients will perform current standard of care CR programming, which will involve traditional MICE. MICE at the Cardiac Rumsey Centre will consist of either track walking/jogging or treadmill walking/jogging for approximately 30-40 minutes, performed at an intensity of 60-80% of VO2peak, in addition to a warm-up and cool down period. In the second month of the study intervention, patients will begin to perform AIT three days per week, which involves performing 4-minute intervals at greater than 90% of peak heart rate, separated by 3-minutes of active recovery, with one of those AIT exercise sessions occurring at the Rumsey Centre under supervision, and 2 sessions per week of MICE, which will again consist of the 30-40 minutes of walking/jogging at an intensity of 60-80% of VO2peak, with an allotted warm up and cool down period.
Study: NCT01334957

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen
Description: 800 mg intravenous ibuprofen administered intravenously over 5-10 minutes
Study: NCT03285464

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Triplanar Rotary Resistance
Description: Trunk group will strengthen the hip using the trunk as a lever to access the hip. The hip group will use femur as the lever to strengthen the hip.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Triplanar Rotary Resistance
Description: Trunk group will strengthen the hip using the trunk as a lever to access the hip. The hip group will use femur as the lever to strengthen the hip.
Study: NCT03880149

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3
Description: Each omega-3 capsule contains 600 mg, including 400 mg EPA + 200 mg Docosahexaenoic acid (DHA) and 400 IU of vitamin E for 5 omega-3 capsules. Omega-3 dosage: 1 g per 15 kg body mass

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Medium-chain triglyceride (MCT) and vitamin E
Study: NCT05807230

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Three-level network rehabilitation services within the medical alliance
Description: Data of all levels of medical and health institutions in Huzhou region are shared, and advanced rehabilitation technologies are passed down from senior hospitals to grassroots medical institutions. Grassroots medical institutions to patients home for 3 months of rehabilitation training.
Study: NCT02173808

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: levonorgestrel butanoate
Study: NCT01354457

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epratuzumab and 90Y-Epratuzumab
Description: Sequential injections of each product with an escalating dose for radiolabeled Epratuzumab between patients
Study: NCT00955318

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KW-6500
Description: Subcutaneous injection of 1to 6 mg of KW-6500 for the OFF state
Study: NCT01893203

Intervention type: DRUG
Group type: OTHER
Intervention: BF-200 ALA cream
Description: The symmetrical treatment areas will be randomized for treatments. First the treatment area will be wiped ethanol. Then sun protection factor (SPF) 20 cream will be applied on all sun-exposed areas of the skin. Then a 0,25mm layer application of Ameluz cream on the area. After appropriate absorption time of 30 minutes, the patients will be taken to the hospital balcony for 2 hour illumination with daylight to accomplish the phototoxic reaction. Maximum dosage will be 2 grams. The treatment will be repeated after 2 weeks for thicker gr II-III lesions with the same protocol.

Intervention type: DRUG
Group type: OTHER
Intervention: MAL cream
Description: The symmetrical treatment areas will be randomized for treatments. First the treatment area will be wiped ethanol. Then SPF20 sun protection cream will be applied on all sun-exposed areas of the skin. Then a 0,25mm layer application of Metvix cream on the area. After appropriate absorption time of 30 minutes, the patientswill be taken to the hospital balcony for 2 hour illumination with daylight to accomplish the phototoxic reaction. Maximum dosage will be 2 grams. The treatment will be repeated after 2 weeks for thicker gr II-III lesions with the same protocol.
Study: NCT02323243

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Allium  Bulbar Urethral Stent  (BUS) system
Study: NCT03808129

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine and Lidocaine
Description: ESP block was administered under general anesthesia before the surgery. Patients with ESP block, 1: 1 ratio of 0.25% bupivacaine and 0.4 ml / kg of 1% lidocaine
Study: NCT02652065

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acetylcholine iontophoresis
Description: Acetylcholine will be locally delivered to patients by iontophoresis successively on healthy skin and on psoriasis plaque (order determined by randomization).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acetylcholine iontophoresis
Description: Acetylcholine will be locally delivered to patients by iontophoresis successively on healthy skin and on psoriasis plaque (order determined by randomization).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sodium Nitroprussiate iontophoresis
Description: Sodium Nitroprussiate will be locally delivered to patients by iontophoresis successively on healthy skin and on psoriasis plaque (order determined by randomization).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprussiate iontophoresis
Description: Sodium Nitroprussiate will be locally delivered to patients by iontophoresis successively on healthy skin and on psoriasis plaque (order determined by randomization).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ppi water iontophoresis
Description: ppi water will be locally delivered to patients by iontophoresis successively on healthy skin and on psoriasis plaque (order determined by randomization).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ppi water iontophoresis
Description: ppi water will be locally delivered to patients by iontophoresis successively on healthy skin and on psoriasis plaque (order determined by randomization).
Study: NCT01250327

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: bare stent
Description: insertion of a bare metal stent

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: conventional surgery methode
Study: NCT00684684

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chartis System
Description: Assessment of airway flow and pressure
Study: NCT02652065

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laser Doppler recording
Description: Skin blood flow will be recorded by laser Doppler during 2 minutes before iontophoresis, and during 30 minutes following iontophoretic delivery of vasodilators.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laser Doppler recording
Description: Skin blood flow will be recorded by laser Doppler during 2 minutes before iontophoresis, and during 30 minutes following iontophoretic delivery of vasodilators.
Study: NCT01443208

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: desvenlafaxine
Description: one 50 mg desvenlafaxine succinate sustained-release tablet or matching placebo, single dose and once daily dose for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: desvenlafaxine
Description: one 100 mg desvenlafaxine succinate sustained-release tablet or matching placebo, single dose and once daily dose for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: desvenlafaxine
Description: two 100 mg desvenlafaxine succinate sustained-release tablets or matching placebo, single dose and once daily dose for 5 days
Study: NCT02486523

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hygiene promotion sessions
Description: Hygiene promotion sessions are provided weekly to the caretakers at the health center level. They contain 7 main messages this study is trying to get across: Allocate a protected space for children to play, limiting the likelihood of them ingesting soil or animal feces; Wash the child with soap (hand, face) when outside the protected area; Cleaning and rapid burial of children's stools; Key times for hand washing with soap for the child caretaker; Store drinking water in a closed container located in an elevated place out of reach of animals; Drinking water provided to the child should be treated with chlorine or boiled; Once weaned, avoid giving to the child leftover food, or only after warming it again.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Household WASH package
Description: The content of the kit: 200 g soap, aquatab 67 g, 20 liters Jerry can, a cup, a plastic kettle for hand washing and the instructions leaflet.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Household visit
Description: A household visit conducted by village's community health volunteers and ACF intervention staff during and after the treatment, to provide refresh training on the messages and the use of the kit.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Group discussions after successful discharge
Description: Group discussions on hygiene and care practices with mothers at the community level after successful discharge.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group discussions after successful discharge
Description: Group discussions on hygiene and care practices with mothers at the community level after successful discharge.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Outpatient Therapeutic Programme
Description: Home-based treatment and rehabilitation using Ready-to-use Therapeutic Food (RUTF) for children with severe acute malnutrition

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Outpatient Therapeutic Programme
Description: Home-based treatment and rehabilitation using Ready-to-use Therapeutic Food (RUTF) for children with severe acute malnutrition